Publications by authors named "Shuki Oya"

Claim this Profile
T
Thrombophagocytosis by myeloid blasts in acute myeloid leukemia with biallelic CEBPA mutations.
Shuki Oya, Yoshimi Maehiro

Int J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia.
Shuki Oya, Hidetoshi Ozawa, Satoshi Morishige, Yoshimi Maehiro, Masahiro Umeda, Kazutoshi Aoyama

Int J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity.
Shuki Oya, Hidetoshi Ozawa, Takayuki Nakamura, Akira Mori, Sorahiko Ochi, Kazutoshi Aoyama

Int J Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful induction therapy for acute myeloid leukemia under management with extracorporeal membrane oxygenation].
Yusuke Takaki, Toshiyuki Yanai, Tatsuhiro Shibata, Takehiro Honma, Maki Otsuka, Shuki Oya, Kazutoshi Aoyama

Rinsho Ketsueki· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies.
Takayuki Nakamura, Shuki Oya, Hidetoshi Ozawa, Yoshimi Maehiro, Seiya Muta, Kazutoshi Aoyama

Int J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful immunosuppressive therapy in female hemophilia A developing inhibitor after perioperative administration of factor VIII products].
Maki Yamaguchi, Yusuke Takaki, Yoshitaka Yamasaki, Shuki Oya, Takayuki Nakamura, Kazutoshi Aoyama

Rinsho Ketsueki· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternating venetoclax/azacytidine and FLT3 inhibitor treatment for NPM1- and FLT3-mutated acute myeloid leukemia.
Shuki Oya, Hidetoshi Ozawa, Yoshimi Maehiro, Takayuki Nakamura, Yusuke Takaki, Kazutoshi Aoyama

Leuk Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[FLT3-ITD and NPM1 mutation positive acute myeloid leukemia with cuplike blasts mimicking acute promyelocytic leukemia].
Kazutoshi Aoyama, Yoshitaka Yamasaki, Fumihiko Mouri, Yoshimi Maehiro, Yusuke Takaki, Shuki Oya

Rinsho Ketsueki· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Allogeneic hematopoietic stem cell transplantations for relapsed and refractory acute lymphoblastic leukemia following inotuzumab ozogamicin treatment].
Satoshi Morishige, Yoshitaka Yamasaki, Shuki Oya, Takayuki Nakamura, Maki Yamaguchi, Kazutoshi Aoyama

Rinsho Ketsueki· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe drug-induced immune hemolytic anemia due to cefmetazole: A case report.
Masafumi Fukuda, Masakazu Nabeta, Shuki Oya, Osamu Takasu

Int J Clin Pharmacol Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of lymphomatoid granulomatosis with central nervous system involvement successfully treated with IFNα.
Yoshitaka Yamasaki, Satoshi Morishige, Satoru Komaki, Takuya Furuta, Hiroshi Koga, Shuki Oya, Kazutoshi Aoyama

Int J Hematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
Shuki Oya, Satoshi Morishige, Hidetoshi Ozawa, Kensuke Sasaki, Yuichiro Semba, Kazutoshi Aoyama

Int J Hematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Interleukin-6-producing paraganglioma mimicking multicentric Castleman disease].
Shuki Oya, Yoshitaka Yamasaki, Takayuki Nakamura, Satoshi Morishige, Maki Yamaguchi, Kazutoshi Aoyama

Rinsho Ketsueki· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks of Muscle Atrophy in Patients with Malignant Lymphoma after Autologous Stem Cell Transplantation.
Keisuke Hirota, Hiroo Matsuse, Shunji Koya, Ryuki Hashida, Masafumi Bekki, Shuki Oya

Phys Ther Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful correction of factor V deficiency of patient-derived iPSCs by CRISPR/Cas9-mediated gene editing.
Takayuki Nakamura, Satoshi Morishige, Hidetoshi Ozawa, Kenji Kuboyama, Yoshitaka Yamasaki, Shuki Oya, Kazutoshi Aoyama

Haemophilia· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.
Satoshi Morishige, Marina Nishi, Hiroshi Saruta, Fumiko Arakawa, Yoshitaka Yamasaki, Shuki Oya, Kazutoshi Aoyama

Int J Hematol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough infection of Geotrichum capitatum during empirical caspofungin therapy after umbilical cord blood transplantation.
Shuki Oya, Tsuyoshi Muta

Int J Hematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis